Eduardo Abeliuk (born in Santiago, Chile) is a Silicon Valley entrepreneur and technologist. He co-founded TeselaGen Biotech, a Synthetic Biology company based in San Francisco, a spin-off from the Lawrence Berkeley National Laboratory.*"Latest JBEI Startup to Speed Up Biotech Industry'" He founded ClassroomTV - an Educational technology company operating in Latin America - and KissMe, one of the early viral Facebook applications.

Early life Abeliuk earned a double bachelor's degree in Physics and in Electrical Engineering from University of Chile. He earned a M.S. in Bioengineering and a Ph.D. in Electrical Engineering from Stanford University.

Career Abeliuk is co-founder and CTO of TeselaGen Biotech, a San Francisco based company that has developed a technological platform for Synthetic Biology. TeselaGen is supported by the U.S. National Science Foundation. He also founded ClassroomTv, an early MOOC platform focusing on corporate online training.

During his PhD, he used computational biology techniques to predicted the existence of novel small RNA molecules, confirmed through biochemistry experiments by Stanford colleagues. One of these RNA molecules, CrfA RNA, is associated with carbon starvation. Abeliuk co-developed a technique used to identify the essential genome of an organism by coupling high-throughput DNA sequencing with transposon mutagenesis.https://patents.google.com/patent/US9150916 Compositions and methods for identifying the essential genome of an organism He was part of the Facebook Class at Stanford University, a group of computer scientists who created a series of successful Facebook applications. He co-founded KissMe in 2007, based on the group's first Facebook application to reach 1 million users 4 weeks after launch, which was subsequently acquired.

Selected publications

References

Further reading

External links Eduardo Abeliuk's homepage "TeselaGen Is Building A Platform For Rapid Prototyping in Synthetic Biology", by Kim-Mai Cutler "Techcrunch" "How To Code A Life", by Allison McCann, "BuzzFeed"